KALA BIO, Inc.
KALA BIO, Inc.24About
KALA BIO is a clinical-stage biopharmaceutical company focused on rare and severe eye diseases, particularly through its mesenchymal stem cell secretome (MSC-S) platform. The company is also developing an on-premises AI infrastructure platform, Researgency.ai, for biotechnology research applications, aiming to provide AI-driven analytical tools for proprietary biological data.
Frequently asked
What type of investor is KALA BIO, Inc.?
KALA BIO is a clinical-stage biopharmaceutical company focused on rare and severe eye diseases, particularly through its mesenchymal stem cell secretome (MSC-S) platform. The company is also developing an on-premises AI infrastructure platform, Researgency.ai, for biotechnology research applications, aiming to provide AI-driven analytical tools for proprietary biological data.
What kind of firm is KALA BIO, Inc.?
KALA BIO, Inc. is a VC.
What is KALA BIO, Inc.'s assets under management?
KALA BIO, Inc. manages approximately $41M in assets.
Where is KALA BIO, Inc. based?
KALA BIO, Inc. is based in Arlington, United States.
What sectors does KALA BIO, Inc. focus on?
KALA BIO, Inc. focuses on Biotechnology, AI, Ophthalmology, Healthcare.
Comments
No comments yet. Be the first to share your take.